Filing search / Olema Pharmaceuticals, Inc. / "Audit"

Search information

Olema Pharmaceuticals, Inc.

Companies

"Audit"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

69 results

Newest first Best match first

10-Q

2024 Q2

EX-31.2

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee

6 Aug 24

4:15pm

10-Q

2024 Q2

EX-10.2

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

: a. Member of the Audit Committee: $8,000 b. Member of the Compensation Committee: $6,000 c. Member of the Nominating and Corporate Governance … Committee: $5,000 Annual Committee Chair Service Retainer (inclusive of Committee Member Service Retainer): a. Chairperson of the Audit Committee

6 Aug 24

4:15pm

10-Q

2024 Q2

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes … , once additional data have been received and fully evaluated. Top-line data also remain subject to audit and verification procedures that may result

6 Aug 24

4:15pm

10-Q

2024 Q2

EX-31.1

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee

6 Aug 24

4:15pm

8-K

OLMA Olema Pharmaceuticals, Inc.

14 Jun 24

Submission of Matters to a Vote of Security Holders

4:39pm

Voting Results For Against Abstain The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of Ernst

8 May 24

4:15pm

8 May 24

4:15pm

10-Q

r67lgq

Quarterly report

8 May 24

4:15pm

DEFA14A

6q0y5cunv1fbte

26 Apr 24

Additional proxy soliciting materials

26 Apr 24

5:07pm

11 Mar 24

4:15pm

10-K

yc1xeij 8h2lu39dvs

Annual report

11 Mar 24

4:15pm

11 Mar 24

4:15pm

11 Mar 24

4:15pm

Entry into a Material Definitive Agreement

7 Nov 23

4:12pm

10-Q

bp5nho

Quarterly report

7 Nov 23

4:12pm

7 Nov 23

4:12pm

Olema Oncology Announces Combined Financing for Up to $180 Million

8 Aug 23

4:12pm

Filing search / Olema Pharmaceuticals, Inc. / "Audit"

69 results

Top filers

Top filing types

Recent filing years